MAP microba life sciences limited

I've been following Microba since IPO and believe the current...

  1. 1,528 Posts.
    lightbulb Created with Sketch. 900
    I've been following Microba since IPO and believe the current share price close to cash backing is offering value and a margin of safety.

    There are three parts of the business: services, clinical pipeline and data. The upcoming quarterly will give an early indication if their services momentum in filtering through to revenue.

    Data however is the key that will drive down pipeline discovery costs and eventually make this an acquisition target.

    The gut is the 'second brain'.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
8.9¢
Change
-0.003(3.26%)
Mkt cap ! $45.83M
Open High Low Value Volume
9.5¢ 9.5¢ 8.9¢ $67.73K 746.9K

Buyers (Bids)

No. Vol. Price($)
2 69744 8.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 65000 2
View Market Depth
Last trade - 15.59pm 01/08/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.